Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients.

Hegazy SK, Tharwat S, Hassan AH

Open source

DOI
10.1515/med-2023-0768
Published
2023
Container
Open medicine (Warsaw, Poland)
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1515/med-2023-0768,
  title = {Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients.},
  author = {Hegazy SK and Tharwat S and Hassan AH},
  year = {2023},
  journal = {Open medicine (Warsaw, Poland)},
  doi = {10.1515/med-2023-0768},
  url = {https://doi.org/10.1515/med-2023-0768}
}

RIS

TY  - JOUR
TI  - Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients.
AU  - Hegazy SK
AU  - Tharwat S
AU  - Hassan AH
PY  - 2023
JO  - Open medicine (Warsaw, Poland)
DO  - 10.1515/med-2023-0768
UR  - https://doi.org/10.1515/med-2023-0768
ER  - 

APA

SK, H., S, T., & AH, H. (2023). Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients.. Open medicine (Warsaw, Poland). https://doi.org/10.1515/med-2023-0768

Source records